Background: Acute pancreatitis is usually a mild and self-limiting disease. About 25 % of patients have severe episode with mortality up to 30%. Early identifi cation of these patients has potential advantages of aggressive treatment at intensive care unit or transfer to higher centre. Several scoring systems are available to predict severity of acute pancreatitis but are cumbersome, take 24 to 48 hours and are dependent on tests that are not universally available. Haematocrit has been used as a predictor of severity of acute pancreatitis but some have doubted its role. Objectives: To study the signifi cance of haematocrit in prediction of severity of acute pancreatitis. Methods: Patients admitted with fi rst episode of acute pancreatitis from February 2014 to July 2014 were included. Haematocrit at admission and 24 hours of admission were compared with severity of acute pancreatitis. Mean, analysis of variance, chi square, pearson correlation and receiver operator characteristic curve were used for statistical analysis. Results: Thirty one patients were included in the study with 16 (51.61%) male and 15 (48.4%) female. Haematocrit at 24 hours of admission was higher in severe acute pancreatitis (P value 0.003). Both haematocrit at admission and at 24 hours had positive correlation with severity of acute pancreatitis (r: 0.387; P value 0.031 and r: 0.584; P value 0.001) respectively. Area under receiver operator characteristic curve for haematocrit at admission and 24 hours were 0.713 (P value 0.175, 95% CI 0.536 -0.889) and 0.917 (P value 0.008, 95% CI 0.813 -1.00) respectively. Conclusion: Haematocrit is a simple, cost effective and widely available test and can predict severity of acute pancreatitis.
INTRODUCTION
A cute pancreatitis (AP) is an acute infl ammatory disease of pancreas that frequently affects the peripancreatic tissue and less frequently the systemic organs 1 . Severe form of disease is characterized by persistent organ failure, pancreatic necrosis and other local and systemic complications with mortality up to 30% [2] [3] [4] [5] . Early identifi cation of these patients has advantages of early triage into severe group and hence, early fl uid resuscitation, early admission to intensive care unit or transfer to another centers with intensive care facility.
There are several clinical, biochemical and imaging systems and scores to predict the severity of AP like Ranson's criteria, Acute Physiology and Chronic Health Evaluation (APACHE II), Computerized Tomography (CT) criteria, Bedside Index for Severity in Acute Pancreatitis (BISAP) score etc 4, [6] [7] [8] . However most of these scoring systems are cumbersome, take around 24 to 48 hours to calculate or rely on diagnostic tests that are not available widely 9 . Therefore, the search of a simple, readily available, economical, non-invasive and reproducible tool is going on 10 . Studies have shown that haematocrit at admission is a useful tool to evaluate the severity of AP however some doubt the role of haematocrit as a prognostic marker 6, [11] [12] [13] [14] [15] [16] [17] . Hence, the role of haematocrit in determination of severity of acute pancreatitis is still controversial.
We conducted a descriptive study with an aim to study the signifi cance of haematocrit at admission and at 24 hours of admission in predicting the severity of AP. Demographic data, history, relevant physical fi ndings, serum amylase, liver function test including haematocrit at admission and at 24 hours of admission, abdominal ultrasound, CECT abdomen and MRI abdomen (if done) fi ndings were noted. Haematocrit at admission and 24 hours of admission were compared with severity of AP based on revised Atlanta classifi cation.
METHODS

Statistical Analysis
Categorical variables were expressed as absolute or relative frequencies and continuous variables were expressed as mean±SD. Analysis of Variance (ANOVA) test was used to analyze continuous variables between different groups while chi square test was used on categorical variables. Pearson correlation was used to test correlation of haematocrit with the severity of pancreatitis. Receiver Operator Characteristic (ROC) curve was plotted for range of haematocrit levels at admission and at 24 hours of admission as prognostic factor for severity of acute pancreatitis. Classifi cation of severity based on revised Atlanta classifi cation was used as gold standard of severity. p value of < 0.05 was considered statistically signifi cant. Statistical Package for the Social Science (SPSS) version 20.0 was used for analysis of data.
RESULTS
Thirty one patients with fi rst episodes of acute pancreatitis were included in the study. Seven patients were excluded from the study out of them fi ve patients had associated liver disease and two patients had chronic kidney disease. Both haematocrit at admission and haematocrit at 24 hours had positive correlation with severity of AP with correlation coeffi cient of 0.387 (P value 0.031) and 0.584 (P value 0.001) respectively. Area under ROC curve for haematocrit at admission (fi gure 1) was 0.713 (P value 0.175, 95 % CI 0.536 -0.889) and that for haematocrit at 24 hours of admission (fi gure 2) was 0.917 (P value 0.008, 95 % CI 0.813 -1.00). Coordinates of ROC curve shows that cut-off value of 44 % is 100 % sensitive and 88.9 % specifi c in prediction of severity of pancreatitis for haematocrit at 24 hours of admission. 
DISCUSSION
Severe acute pancreatitis can occur in about 25% of patients with AP with mortality up to 30% 5 . Severe form of disease is characterized by persistent organ failure, pancreatic necrosis and other local and systemic complications 2 . Identifi cation of patients at risk of severe disease early in the course of disease allows early triage of the patients, early fl uid resuscitation, admission to a high care or intensive care units and transfer of patients to specialized tertiary centers if patient present to a primary care centers. Similarly proper identifi cation of patients not at risk of severe disease may be managed out of intensive care units and at general hospitals. This can help in judicial use of resources and avoid unnecessary referral and overload at tertiary care hospital.
A case control study comparing haemoconcentration in patients with necrotizing pancreatitis with that in mild pancreatitis showed that the haematocrit at admission of ≥ 47% was seen in more patients with necrotizing pancreatitis than mild pancreatitis (11/32 vs 3/32; P value 0.03). At 24 hours of admission failure of admission haematocrit to decrease was also signifi cant in necrotising pancreatitis group (26/32 vs 4/32; P value < 0.001) 11 . Another prospective study showed that haematocrit at admission ≥ 44% and/or failure of haematocrit to decrease at 24 hours of admission was associated with the development of necrotizing pancreatitis and organ failure with negative predictable value for necrotizing pancreatitis and organ failure of 96% and 97% respectively 12 . However, Troche et al 16 studied association of hematocrit at admission or at 24 hours after admission with severe AP, organ failure, and pancreatic necrosis and found that hematocrit was not a good predictor of severity in AP. Their results showed that the sensitivity, specifi city and positive predictive values for necrosis and organ failure were low but negative predictive values was between 61% to 86%, being highest for organ failure 16 . Current study showed that the level of haemoconcentration as evidenced by haematocrit level was higher as the grades of severity increases both at admission and 24 hours of admission but statistically signifi cant difference was seen in the level of haematocrit at 24 hours of admission (P value . Both haematocrit at admission and at 24 hours had positive correlation with severity of AP with correlation coeffi cient of 0.387 (P value -.031) and 0.584 (P value .001) respectively which is statistically signifi cant. Current study also showed that the cut-off value for haematocrit at 24 hours of admission at 44% is 100% sensitive and 88.9% specifi c in prediction of severity of pancreatitis similar to Brown et al 12 .
A few studies have shown that haemoconcentration predicts pancreatic necrosis and mortality only among patient transferred to their hospital from other hospitals and not in patients directly admitted to their hospital 13, 14 . However another study showed that among the patients with haemoconcentration in AP who were directly admitted to their hospital within 12 hours of pain had severe pancreatitis 18 . A study observed high negative predictive value of haematocrit and suggested that in the absence of hemoconcentration, contrast-enhanced CT may be unnecessary on admission unless the patient does not improve 15 . The negative predictable value of haematocrit has been used in Harmless Acute Pancreatitis Score (HAPS) in which absence of haemoconcentration (Haematocrit< 43% for male and < 39.6% for female) along with absence of rebound tenderness and serum creatinine < 2 mg/dl has been found to be sensitive and specifi c to predict non severe acute pancreatitis 19, 20 . Similarly haematocrit has been used in panc 3 score to predict severe pancreatitis on presentation and authors stated that "The prognostic value of the scoring system seems to depend mainly on the serum haematocrit" signifying the role of haematocrit in prediction of severe AP 9 .
Haematocrit is a simple haemotological test. It is cost effective, less time consuming, reproducible and is even available in primary health care facilities. So it can be used even in primary health care centre to predict severe course in AP and initiate early treatment and early transfer to higher centre. It is also important in higher centers for proper risk stratifi cation even by nonspecialists for early referral to concerned department and intensive care units for optimal level of care.
Our study has certain limitations. It is a single centre study with small sample size and hence, the results may not be generalized. A multicentre study with larger sample size would be required.
CONCLUSION
Haematocrit is a simple, cost effective, reproducible and widely available test that can be used for early prediction of severity in acute pancreatitis presenting with the fi rst episode and in acute pancreatitis without fl uid resuscitation. It can be used even in primary health centre and emergency department of higher centre for early risk stratifi cation and early transfer to intensive care units.
